Suppr超能文献

δ 型阿片受体激动剂可改变 μ 型阿片受体激动剂与 μ-δ 型受体异源寡聚体的结合。

Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.

机构信息

Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

出版信息

Br J Pharmacol. 2010 Nov;161(5):1122-36. doi: 10.1111/j.1476-5381.2010.00944.x.

Abstract

BACKGROUND AND PURPOSE

µ- and δ-opioid receptors form heteromeric complexes with unique ligand binding and G protein-coupling profiles linked to G protein α z-subunit (Gα(z) ) activation. However, the mechanism of action of agonists and their regulation of the µ-δ receptor heteromer are not well understood.

EXPERIMENTAL APPROACH

Competition radioligand binding, cell surface receptor internalization in intact cells, confocal microscopy and receptor immunofluorescence techniques were employed to study the regulation of the µ-δ receptor heteromer in heterologous cells with and without agonist exposure.

KEY RESULTS

Gα(z) enhanced affinity of some agonists at µ-δ receptor heteromers, independent of agonist chemical structure. δ-Opioid agonists displaced µ-agonist binding with high affinity from µ-δ heteromers, but not µ receptor homomers, suggestive of δ-agonists occupying a novel µ-receptor ligand binding pocket within the heteromers. Also, δ-agonists induced internalization of µ-opioid receptors in cells co-expressing µ- and δ-receptors, but not those expressing µ-receptors alone, indicative of µ-δ heteromer internalization. This dose-dependent, Pertussis toxin-resistant and clathrin- and dynamin-dependent effect required agonist occupancy of both µ- and δ-opioid receptors. In contrast to µ-receptor homomers, agonist-induced internalization of µ-δ heteromers persisted following chronic morphine exposure.

CONCLUSIONS AND IMPLICATIONS

The µ-δ receptor heteromer may contain a novel δ-agonist-detected, high-affinity, µ-receptor ligand binding pocket and is regulated differently from the µ-receptor homomer following chronic morphine exposure. Occupancy of both µ- and δ-receptor binding pockets is required for δ-agonist-induced endocytosis of µ-δ receptor heteromers. δ-Opioid agonists target µ-δ receptor heteromers, and thus have a broader pharmacological specificity than previously identified.

摘要

背景与目的

μ 型和 δ 型阿片受体与独特的配体结合和 G 蛋白偶联特性形成异源二聚体,与 G 蛋白 αz 亚基(Gα(z))的激活有关。然而,激动剂的作用机制及其对 μ-δ 受体异源二聚体的调节尚不清楚。

实验方法

采用竞争放射配体结合、完整细胞表面受体内化、共聚焦显微镜和受体免疫荧光技术,研究了在有和没有激动剂暴露的情况下,异源细胞中 μ-δ 受体异源二聚体的调节。

主要结果

Gα(z)增强了一些激动剂在 μ-δ 受体异源二聚体中的亲和力,而与激动剂的化学结构无关。δ 型阿片受体激动剂以高亲和力从 μ-δ 异源二聚体中置换 μ 型激动剂结合,但不置换 μ 受体同源二聚体,提示 δ 型激动剂占据了异源二聚体中 μ 受体的一个新的配体结合口袋。此外,δ 型激动剂诱导共表达 μ-和 δ-受体的细胞中 μ 型阿片受体内化,但不诱导仅表达 μ 受体的细胞内化,提示 μ-δ 异源二聚体内化。这种剂量依赖性、百日咳毒素抗性、网格蛋白和动力蛋白依赖性效应需要 μ-和 δ-阿片受体的激动剂占据。与 μ 受体同源二聚体不同,慢性吗啡暴露后,激动剂诱导的 μ-δ 异源二聚体内化持续存在。

结论和意义

μ-δ 受体异源二聚体可能包含一个新的 δ-激动剂检测的高亲和力 μ 受体配体结合口袋,并且在慢性吗啡暴露后,其调节方式与 μ 受体同源二聚体不同。需要占据 μ-和 δ-受体的结合口袋,才能引起 δ-激动剂诱导的 μ-δ 受体异源二聚体内化。δ 型阿片受体激动剂靶向 μ-δ 受体异源二聚体,因此具有比以前鉴定的更广泛的药理学特异性。

相似文献

引用本文的文献

8
Opioids Resistance in Chronic Pain Management.慢性疼痛管理中的阿片类药物耐药性
Curr Neuropharmacol. 2017 Apr;15(3):444-456. doi: 10.2174/1570159X14666161101092822.
10
Molecular Pharmacology of δ-Opioid Receptors.δ-阿片受体的分子药理学
Pharmacol Rev. 2016 Jul;68(3):631-700. doi: 10.1124/pr.114.008979.

本文引用的文献

2
Guide to Receptors and Channels (GRAC), 4th Edition.《受体与通道指南》(第4版)
Br J Pharmacol. 2009 Nov;158 Suppl 1(Suppl 1):S1-254. doi: 10.1111/j.1476-5381.2009.00499.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验